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INTRODUCTION
The Women’s Health and Cancer Rights Act (WHCRA) 
was federally enacted in 1998 to ensure that all group and 
individual health plans provide insurance coverage for 
reconstruction after mastectomy regardless of diagnosis. 
WHCRA also extended coverage for reconstruction or re-
vision of the contralateral breast to produce a symmetric 
appearance. This legislation represented a paradigm shift 
in the availability of reconstruction by eliminating eco-
nomic hurdles to care.
Although increasing number of women opted for 
breast reconstruction in the years after the WHCRA, this 
trend was not consistent across all demographic groups. 
Significant disparities exist based on access to health care, 
age, race, geographic location, and patient education.1–15 
As a result, patient education events, such as Breast Recon-
struction Awareness Day instituted in 2012, have emerged 
to increase awareness of breast reconstruction. More re-
cently, the Breast Cancer Patient Education Act, passed 
in December 2015, was designed to implement an educa-
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Background: By eliminating economic hurdles, the Women’s Health and Can-
cer Rights Act of 1998 represented a paradigm shift in the availability of breast 
reconstruction. Yet, studies report disparities among Medicare-insured women. 
These studies do not account for the inherent differences in age and comorbidi-
ties between a younger privately insured and an older Medicare population. We 
examined immediate breast reconstruction (IBR) utilization between a matched 
pre- and post-Medicare population.
Methods: Using the Nationwide Inpatient Sample database (1992–2013), breast 
cancer patients undergoing IBR were identified. To minimize confounding medi-
cal variables, 64-year-old privately insured women were compared with 66-year-old 
Medicare-insured women. Demographic data, IBR rates, and complication rates 
were compared. Trend over time was plotted for both cohorts.
Result: A total of 21,402 64-year-old women and 25,568 66-year-old women were 
included. Both groups were well matched in terms of demographic type of recon-
struction and complication rates. 72.3% of 64-year-old and 71.2 of % 66-year-old 
women opted for mastectomy. Of these, 25.5% (n = 3,941) of 64-year-old privately 
insured and 17.7% (n = 3,213) of 66-year-old Medicare-insured women underwent 
IBR (P < 0.01). During the study period, IBR rates increased significantly in both 
cohorts in a similar cohort.
Conclusion: This study demonstrates significant increasing IBR rates in both co-
horts. Moreover, after an initial slower upward trend, after a decade, IBR in 66-year-
old Medicare-insured women approached similar rates of breast reconstruction 
among those with private insurance. Trends in unilateral versus bilateral mas-
tectomy are also seen. (Plast Reconstr Surg Glob Open 2018;6:e1552; doi: 10.1097/
GOX.0000000000001552; Published online 12 January 2018.)
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tional campaign to inform women in minority and lower 
socioeconomic groups about their options for breast re-
construction.16
To date, there is a large body of available literature to 
suggest that insurance status plays a role key in patients’ 
access to immediate breast reconstruction (IBR).1,2,5–7,9,17–
19 These reports suggest that women with Medicare are 
significantly less likely to undergo breast reconstruction 
when compared to women with private insurance. How-
ever, many of these studies do not always take the inherent 
differences in age and comorbidities between a younger 
privately insured population and an older Medicare popu-
lation into account.2,4,5,8,20–22 This study aims to bridge this 
knowledge gap, by performing a matched cohort analysis 
to examine the differences between pre- and post-Medi-
care and utilization of breast reconstruction in a matched 
cohort.
METHODS
Patient data were obtained from the Healthcare Cost 
and Utilization Project Nationwide Inpatient Sample 
(NIS) database. The NIS, compiled by the Agency for 
Healthcare Research and Quality (Rockville, Md.), rep-
resents the largest all-payer inpatient administrative data-
base in the United States. It contains data from over 1000 
hospitals and more than 8 million hospital stays annually 
and is designed to approximate a 20% sample of all hospi-
tal discharges, which includes all nonfederal, short-term, 
general, and other specialty hospitals, including public 
hospitals and academic institutions.23
Patient Selection
The International Classification of Diseases, Ninth Re-
vision (ICD-9) procedural coding terminology was used to 
identify all patients who underwent any type of IBR; all 
implant-based and autologous techniques of breast recon-
struction were included. To make the study population 
as similar as possible and minimize confounding medical 
variables, a cohort of 64-year-old women with private in-
surance was compared with a cohort of 66-year-old women 
with Medicare. Demographic data, IBR rates, and major 
complication rates were compared between these 2 co-
horts over a 15-year period from 1998 to 2013. Trend over 
time was plotted for the years 1992 to 2013 to provide an 
overview of the years before the WHCRA act.
Patients diagnosed with invasive breast cancer (ICD-9 
diagnosis codes 174.0, 174.1, 174.2, 174.3, 174.4, 174.5, 
174.6, 174.8 and 174.9) undergoing unilateral or bilateral 
mastectomy were included. Patients with multiple ICD-9 
procedure codes or with an additional prophylactic mas-
tectomy code were classified as having bilateral mastecto-
my. Implant-based breast reconstructions were defined as 
either placement of immediate silicone implant or tissue 
expander after mastectomy. Autologous breast reconstruc-
tions included both pedicled and free-tissue options: la-
tissimus dorsi flap, pedicled transverse rectus abdominis 
muscle flap, free transverse rectus abdominis muscle flap, 
deep inferior epigastric perforator flap, superficial infe-
rior epigastric artery perforator flap, or gluteal artery per-
forator flaps (see Table, Supplemental Digital Content 1, 
which shows the ICD-9 procedure codes for mastectomy, 
implant-based and autologous breast reconstruction, 
http://links.lww.com/PRSGO/A632). Male patients and 
those of unknown gender or age were excluded. Cases 
of breast reconstruction without concurrent mastectomy 
were considered delayed and were also excluded from 
analysis.
Analyzed Variables
The analyzed variables included calendar year, geo-
graphic region, race, hospital status (teaching or non-
teaching, and urban or rural), and number of hospital 
beds. The hospital’s geographic region was broken down 
into 4 areas: Northeast (Maine, N.H., Vt., Mass., R.I., 
Conn., N.Y., N.J., Pa.), Midwest (Ohio, Ind., Ill., Mich., 
Wis., Minn., Iowa, Mo., N.Dak., S.Dak., Neb., Kans.), 
South (Del., Md., D.C., Va., W.Va., N.C., S.C., Ga., Fla., Ky., 
Tenn., Ala., Miss., Ark., La., Okla., Tex.), and West (Mont., 
Idaho, Wyo., Colo., N.Mex., Ariz., Utah, Nev., Wash., Ore., 
Calif., Alaska, Hawaii).
Hospital teaching status is determined by NIS as those 
hospitals with American Medical Association-approved 
residency programs, or are members of the council of 
Teaching Hospitals, or have a ratio of full-time residents 
to beds of 0.25 or greater.24 The number of hospital beds 
was organized into groups determined by the NIS as fol-
lows: small (1–49 beds for rural hospitals, 1–99 for urban 
nonteaching hospitals, and 1–299 beds for urban teaching 
hospitals); medium (50–99 for rural hospitals, 100–199 
for urban nonteaching hospitals, and 300–499 for urban 
teaching hospitals); and large (>100 for rural hospitals, 
>200 beds for urban nonteaching hospitals, and >500 for 
urban teaching hospitals).10,25 Comorbidities identified us-
ing ICD-9 codes were used to calculate the Charlson co-
morbidity index (CCI).26 The CCI has been validated for 
administrative databases and has been used previously to 
examine the influence of comorbidity on breast cancer 
treatment and outcomes.26–28 CCI score was divided into 
4 groups; CCI score 0, CCI score 1, CCI score 2, and CCI 
score ≥3. Postoperative complications were determined by 
using ICD-9 codes. The NIS does not contain information 
on patient outcomes after discharge because it records in-
patient data only. Complications occurring after hospital 
discharge were therefore not captured in our analysis.
Statistical Analysis
The frequencies of categorical variables are expressed 
as a percentage of the group of origin. Categorical vari-
ables were compared using Chi-square analyses. Trends 
were analyzed using the Cochran–Armitage test. All analy-
ses were performed using IBM SPSS Version 22.0 (IBM 
Corp., Armonk, N.Y.), and statistical significance was set 
at P < 0.05.
RESULTS
During the study period, a total of 21,402 women 
with private insurance (age 64) and 25,568 women with 
Medicare (age 66) were diagnosed with invasive breast 
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cancer and included in the study. Of these, 72.3% 
(n = 15,469) within the privately insured cohort and 
71.2% (n = 18,194) within the Medicare cohort opted 
for mastectomy (P = 0.007). During the study period, 
rates of unilateral mastectomy decreased significant-
ly, whereas rates of bilateral mastectomy increased 
significantly in both groups. Unilateral mastecto-
my decreased from 96.8% in 1992 to 49.1% in 2013 
(P < 0.001) in the privately insured group (Fig. 1A). 
Similar trends were seen in Medicare cohort: unilateral 
mastectomy decreased from 96.5% in 1992 to 65.5% in 
2013 (P < 0.001) (Fig. 1B). Bilateral mastectomy conse-
quently increased from 3.5% to 50.9% in the privately 
insured cohort (P < 0.001) and from 3.2% to 34.5% in 
the Medicare-insured cohort (P < 0.001) between 1992 
and 2013 (Figs. 1A, B).
Table 1 demonstrates the overall characteristics of 
patients who underwent postmastectomy IBR. Overall, 
25.5% (n = 3,941) of the privately insured patients and 
17.7% (n = 3,213) of the Medicare-insured patients under-
went IBR (P < 0.001). No significant differences were seen 
between the 2 groups with respect to type of reconstruc-
tion: implant, autologous, or combined (P = 0.225). The 
majority of women in both cohorts were white (P < 0.001), 
were operated on in an urban (P < 0.040), teaching hos-
pital (P < 0.004), with a large bed size (P < 0.025), and 
had a length of stay of 2 days (P = 0.005). Most of privately 
insured women underwent IBR in the Northeast region 
(29.9%), whereas the most Medicare-insured women un-
derwent IBR in the Southern region (30.9%) (P < 0.001). 
No significant difference was seen between the groups in 
terms of complications or CCI (P = 0.444) (Table 2).
Fig. 1. rates of unilateral and bilateral mastectomy among (a) 64-year-old privately insured women and 
(B) 66-year-old Medicare-insured women. cochrane–armitage test for trend, P < 0.001 in both cohorts.
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Finally, when looking at the trend over time, IBR in-
creased significantly in both privately insured women and 
Medicare-insured women (Fig. 2). IBR increased from 
3.9% in 1992 to 47.2% in 2013 among privately insured 
patients (P < 0.001). A similar upward trend was seen in 
Medicare-insured women, with IBR rates increasing from 
2.3% in 1992 to 43.7% in 2013 (P < 0.001) (Fig. 2). The 
difference in IBR rates between the 2 cohorts is demon-
strated in Figure 3. After an initial increase in differences 
of IBR utilization to 2006 (P < 0.001), a significant decline 
in different rates is observed up to 2013 (P < 0.001).
DISCUSSION
Since the passage of the WHCRA, which mandated cov-
erage of breast reconstruction, there has been an increase 
Table 1. Summary of Patient Characteristics
 
Privately Insured Medicare Insured
Pn % n %
Breast cancer (n) 21,402 25,568  
Mastectomy 15,469 72.3 18,194 71.2 0.007
Postmastectomy IBR 3,941 25.5 3,213 17.7 0.001
Type of IBR     0.225
  Implant 3,212 81.5 2,589 80.6  
  Autologous 440 11.2 353 11.0  
  Combined 289 7.3 271 8.4  
Reconstruction     0.001
  Unilateral 2,325 59.0 2,107 65.6  
  Bilateral 1,616 41.0 1,106 34.4  
Race     0.001
  White 2,878 73.0 2,330 72.5  
  Black 210 5.3 213 6.6  
  Hispanic 142 3.6 134 4.2  
  Asian/Pacific Islander 87 2.2 33 1.0  
  Other 624 15.8 502 15.6  
Hospital type     0.004
  Nonteaching 1,542 39.2 1,362 42.6  
  Teaching 2,390 60.8 1,836 57.4  
Hospital location     0.040
  Rural 109 2.8 116 3.6  
  Urban 3,822 97.2 3,082 96.4  
Hospital bed size     0.025
  Small 409 11.5 316 10.9  
  Medium 715 20.1 663 22.8  
  Large 2,438 68.4 1,923 66.3  
Length of stay (d)     0.005
  0 9 0.2 4 0.1  
  1 1,219 30.9 1,085 33.8  
  2 1,529 38.8 1,252 39.0  
  3 623 15.8 498 15.5  
  4+ 560 14.2 373 11.6  
Region     0.001
  Northeast 1,178 29.9 877 27.3  
  Midwest 918 23.3 595 18.5  
  South 1,023 26.0 994 30.9  
  West 822 20.9 787 23.2  
Table 2. Comparison of Complication Rates
 
Privately Insured Medicare Insured
Pn % n %
CCI     0.444
  0 0 0.0 0 0.0  
  1 0 0.0 0 0.0  
  2 1,369 34.7 1,144 35.6  
  ≥3 2,572 65.3 2,069 64.4  
Complications      
  Seroma 27 0.7 10 0.3 0.028
  Hematoma 73 1.0 50 1.6 0.015
  Wound dehiscence 5 0.1 5 0.2 0.746
  Wound infection 25 0.6 19 0.6 0.817
  Deep venous thrombosis 5 0.1 10 0.3 0.090
  Respiratory failure 15 0.4 8 0.2 0.328
  Renal insufficiency 10 0.3 9 0.3 0.829
  Urinary tract infection 15 0.4 10 0.3 0.621
  Sepsis 5 0.1 0 0.0 0.043
  Pneumonia 10 0.3 5 0.2 0.367
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in breast reconstruction among both privately and publicly 
insured patients.2,21,29–31 These findings were corroborated 
by our study. However, the majority of these articles re-
ported disparities in Medicare-insured women. A recent 
report by Wexelman et al., using the NIS database, shows 
that Medicare-insured women are one and a half times less 
likely to undergo IBR when compared with private-insured 
women.4 Reports by Roughton and Yang also demon-
strated similarly low rates of IBR among Medicare-insured 
women.2,18 Notably, these articles have not traditionally ac-
counted for the inherent differences in age and comor-
bidities between the typically younger patients with private 
insurance and the typically older Medicare population.
In this study, we examined and compared the trends of 
IBR between women with Medicare and those with privately 
insurance. To ensure similar groups and minimize bias with 
respect to inherent differences in medical comorbidities, 
only women 64 years of age with private insurance and 66 
years of age with Medicare were included. Not only did this 
study show increased rates of IBR over time in both groups, 
but that after an initial slower upward trend, the rate of IBR 
in Medicare-insured women nearly equaled that among pri-
vate insurance over the duration of this study (Fig. 2). In 
2013, the final year of this study period, IBR was performed 
in 47.2% of privately insured women versus 43.7% of wom-
en in the Medicare group (data not shown).
Fig. 2. rates of iBr over study period. cochrane–armitage test for trend, P < 0.001 in both cohorts.
Fig. 3. Differences of privately insured cohort iBr rates compared with Medicare-insured cohort iBr rates.
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This study demonstrates that in recent years, there 
have been no significant differences in the receipt of IBR 
in both groups. One reason for the disparity in the litera-
ture may be due to the fact that women have been ana-
lyzed based on insurance type (Medicare versus private 
insurance) without regard for patient age and associated 
comorbidities. This distinction is of particular importance 
in the group of patients insured by Medicare where there 
exists a large bimodal distribution of very young and very 
old women, based on eligibility requirements for cover-
age. Unlike previous manuscripts, this study is the first to 
take into account and minimize the differences in comor-
bidities between these groups before analyzing the rates of 
IBR by creating matched cohorts.
There are likely many reasons for the observed in-
creased rates of IBR among breast cancer patients. Pas-
sage of the WHCRA has lessened the financial barriers 
to this procedure among a large number of patients. Ad-
ditionally, the feasibility of prophylactic mastectomy and 
reconstruction has brought to the public’s attention by 
several prominent celebrities. In the future, further pa-
tient education may likely be a driver toward increased ac-
cess to IBR as a favorable option for breast cancer patients. 
Of note, Congress has recently passed the Breast Cancer 
Patient Education Act of 2015, which will allocate more 
resources toward patient education regarding options for 
breast reconstruction after mastectomy.16
Recently, there has been much ongoing speculation 
among plastic surgeons in the literature that declining reim-
bursement rates may be limiting the reconstructive options 
offered to patients.32–35 To this end, Hernandez-Boussard et 
al. examined surgeon fee schedules using the national av-
erage Medicare physician reimbursement rates compared 
with the type of reconstruction chosen by patients. They 
observed a steady decrease in the rates of autologous breast 
reconstruction from 1998 to 2008, which closely paralleled 
a decrease in physician reimbursement over that same time 
period.1 Our study did not show a similar trend, but rather 
that regardless of insurance type, women are being offered 
IBR at ever increasing rates over a similar time period.
There are several limitations of this study that should 
be noted. First, although data from the NIS are a reflec-
tion of the entire country and provide valuable informa-
tion on current practices in the United States, this study is 
retrospective in nature. Second, this study was only limited 
to patients undergoing breast reconstruction in an imme-
diate fashion after mastectomy. Accordingly, as patients 
undergoing delayed reconstruction were excluded from 
this study, there is a cohort of women who ultimately had 
breast reconstruction that were not included in this study. 
Finally, we were unable to conduct a detailed assessment of 
nonsurgical treatment, patient’s background, and the de-
cision-making processes. Nevertheless, this study provides 
a comprehensive overview of a matched cohort privately 
insured and Medicare-insured women undergoing IBR.
CONCLUSION
In this study, we examined IBR utilization between a 
matched population based on insurance type, Medicare or 
private insurance. The results of this study demonstrate a 
significant increase in rates of IBR among women regard-
less of insurance type over the time period of this study. 
Moreover, after an initial slower upward trend, after a de-
cade, IBR in Medicare-insured women approached nearly 
similar rates among those with private insurance. Trends 
in unilateral versus bilateral mastectomy are also seen.
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